Par Pharmaceutical Reports Third-Quarter 20...() (Unaud...),Health

(Unaudited)

Three months ended Nine months ended

September September September September

29, 30, 29, 30,

2007 2006 2007 2006

Revenues:

Net product sales $206,923 $168,951 $589,526 $528,571

Other product related

revenues 5,753 5,028 25,000 12,964

Total revenues 212,676 173,979 614,526 541,535

Cost of goods sold 146,248 118,919 403,854 382,540

Gross margin 66,428 55,060 210,672 158,995

Operating expenses:

Research and development 32,815 12,574 61,131 43,983

Selling, general and

administrative 33,910 40,053 100,466 111,337

Settlements, net (367) - (945) 1,250

Total operating expenses 66,358 52,627 160,652 156,570

Gain on sale of product rights - 3,054 20,000 3,054

Operating income 70 5,487 70,020 5,479

Other (expense) income, net - (38) (49) 66

Equity in loss of joint

venture (107) (18) (335) (497)

Loss on marketable

securities, net - - (4,643) (3,773)

Interest income 3,680 2,098 10,265 6,055

Interest expense (1,691) (1,681) (5,136) (5,069)

Income before provision for

income taxes 1,952 5,848 70,122 2,261

Provision for income taxes 683 1,461 24,541 565

Net income
'/>"/>